261925-88-6 Usage
Description
Tert-butyl 4-[3-(hydroxymethyl)phenyl]piperazine-1-carboxylate is a chemical compound characterized by the molecular formula C20H32N2O3. It is a derivative of piperazine, featuring a tert-butyl group attached to the nitrogen atom and an ester group connected to the carboxylate. The molecule also incorporates a phenyl ring with a hydroxymethyl group, which may contribute to its potential applications in medicinal chemistry. tert-butyl 4-[3-(hydroxymethyl)phenyl]piperazine-1-carboxylate could be instrumental in the development of novel pharmaceuticals or drug delivery systems, although its specific properties and uses require further exploration through research and experimentation.
Uses
Used in Pharmaceutical Development:
Tert-butyl 4-[3-(hydroxymethyl)phenyl]piperazine-1-carboxylate is used as a chemical intermediate in the synthesis of new pharmaceuticals for [application reason]. Its unique structure, including the tert-butyl and hydroxymethyl groups, may offer specific binding or reactivity profiles that are advantageous in the creation of therapeutic agents.
Used in Drug Delivery Systems:
In the field of drug delivery, tert-butyl 4-[3-(hydroxymethyl)phenyl]piperazine-1-carboxylate is used as a component in the design of advanced drug delivery systems for [application reason]. tert-butyl 4-[3-(hydroxymethyl)phenyl]piperazine-1-carboxylate's structural features may facilitate targeted drug delivery, enhance bioavailability, or improve the stability and release profile of therapeutic agents.
Used in Medicinal Chemistry Research:
Tert-butyl 4-[3-(hydroxymethyl)phenyl]piperazine-1-carboxylate serves as a subject of study in medicinal chemistry research for [application reason]. Its synthesis and modification can provide insights into the development of new drug candidates, potentially leading to the discovery of compounds with improved pharmacological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 261925-88-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,1,9,2 and 5 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 261925-88:
(8*2)+(7*6)+(6*1)+(5*9)+(4*2)+(3*5)+(2*8)+(1*8)=156
156 % 10 = 6
So 261925-88-6 is a valid CAS Registry Number.
InChI:InChI=1/C16H24N2O3/c1-16(2,3)21-15(20)18-9-7-17(8-10-18)14-6-4-5-13(11-14)12-19/h4-6,11,19H,7-10,12H2,1-3H3
261925-88-6Relevant articles and documents
Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region
Ngo, Van T.H.,Hoang, Van-Hai,Tran, Phuong-Thao,Ann, Jihyae,Cui, Minghua,Park, Gyungseo,Choi, Sun,Lee, Jiyoun,Kim, Hee,Ha, Hee-Jin,Choi, Kwanghyun,Kim, Young-Ho,Lee, Jeewoo
, p. 1035 - 1049 (2018/02/12)
Pyroglutamate-modified amyloid β peptides (pGlu-Aβ) are highly neurotoxic and promote the formation of amyloid plaques. The pGlu-Aβ peptides are generated by glutaminyl cyclase (QC), and recent clinical studies indicate that QC represents an alternative t
TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE
-
Paragraph 00524, (2017/03/28)
The present invention provides compounds of Formula (I): wherein A is as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.
LIGANDS FOR IMAGING CARDIAC INNERVATION
-
Page/Page column 49, (2008/12/07)
Novel compounds that find use as imaging agents within nuclear medicine applications (PET imaging) for imaging of cardiac innervation are disclosed. These PET based radiotracers may exhibit increased stability, decreased NE release (thereby reducing side
